Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
Meng Geng, Andrew Lin, Thao P. Nguyen
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation
A. John Camm, Gerald V. Naccarelli, Suneet Mittal, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 19, pp. 1932-1948
Open Access | Times Cited: 129
Catheter ablation using pulsed‐field energy: Advantages and limitations compared with conventional energy
Kenji Kuroki, Hiroshi Tada
Journal of Arrhythmia (2025) Vol. 41, Iss. 1
Open Access | Times Cited: 1
Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it
Stanley Nattel, Philip T. Sager, Jörg Hüser, et al.
Cardiovascular Research (2021) Vol. 117, Iss. 7, pp. 1616-1631
Open Access | Times Cited: 49
Mechanisms and Management of Thyroid Disease and Atrial Fibrillation: Impact of Atrial Electrical Remodeling and Cardiac Fibrosis
Abhijit Takawale, Martín Aguilar, Yasmina Bouchrit, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 4047-4047
Open Access | Times Cited: 24
Cardiac arrhythmogenesis: roles of ion channels and their functional modification
Ming Lei, Samantha C. Salvage, Antony P. Jackson, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 4
26‐Week Repeated‐Dose Toxicity Study of a Novel Antiarrhythmic Drug Sulcardine Sulfate in Sprague–Dawley Rats
Liangyu Zhang, Leilei Gu, Hongqun Qiao
Journal of Applied Toxicology (2025)
Closed Access
Anti‐arrhythmic investigations in large animal models of atrial fibrillation
Arnela Saljic, Thomas Jespersen, R Buhl
British Journal of Pharmacology (2021) Vol. 179, Iss. 5, pp. 838-858
Open Access | Times Cited: 22
Characterization of remodeling processes in the atria of atrioventricular block dogs: Utility as an early-stage atrial fibrillation model
Ryuichi Kambayashi, Ai Goto, Akira Takahara, et al.
Journal of Pharmacological Sciences (2024) Vol. 156, Iss. 1, pp. 19-29
Open Access | Times Cited: 2
Cardiac Arrhythmias and Their Management: An In-Depth Review of Current Practices and Emerging Therapies
Anmol K Nagpal, Aditya Pundkar, Akhilesh Singh, et al.
Cureus (2024)
Open Access | Times Cited: 2
Vanoxerine kills mycobacteria through membrane depolarization and efflux inhibition
Alexander D. H. Kingdon, Asti-Rochelle Meosa-John, Sarah M. Batt, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 6
The Synergistic Relationship Between Atrial Fibrillation and Diabetes Mellitus: Implications for Cardiovascular and Metabolic Health
Maryam Mohsin, Hafiz Zeyad, Hareem Khalid, et al.
Cureus (2023)
Open Access | Times Cited: 6
The Complex Relation between Atrial Cardiomyopathy and Thrombogenesis
Elisa D’Alessandro, Joris Winters, Frans A. van Nieuwenhoven, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2963-2963
Open Access | Times Cited: 9
Multiplatform modeling of atrial fibrillation identifies phospholamban as a central regulator of cardiac rhythm
Anaïs Kervadec, James Kezos, Haibo Ni, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 7
Open Access | Times Cited: 4
Further Quinolizidine Derivatives as Antiarrhythmic Agents- 3
Bruno Tasso, Laura Mattioli, Michele Tonelli, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6916-6916
Open Access | Times Cited: 4
Computational Studies Show How the H463R Mutation Turns hKv1.5 into an Inactivation State
Ramisha Anan Rahman, Bushra Zaman, Mohammad Radid Khan, et al.
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 2, pp. 429-439
Closed Access | Times Cited: 1
Exosomal miRNA Changes Associated with Restoration to Sinus Rhythm in Atrial Fibrillation Patients
Pei-Chien Tsai, Albert Min‐Shan Ko, Yulin Chen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3861-3861
Open Access | Times Cited: 1
Translational Studies on Anti-Atrial Fibrillatory Action of Oseltamivir by its in vivo and in vitro Electropharmacological Analyses
Ryuichi Kambayashi, Hiroko Izumi‐Nakaseko, Ai Goto, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 9
Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment
Arvin H. Soepriatna, Tae Yun Kim, Mark C. Daley, et al.
Cellular and Molecular Bioengineering (2021) Vol. 14, Iss. 5, pp. 441-457
Open Access | Times Cited: 8
Common Structural Pattern for Flecainide Binding in Atrial-Selective Kv1.5 and Nav1.5 Channels: A Computational Approach
Yuliet Mazola, José Carlos Estanislao Márquez Montesinos, David Ramírez, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1356-1356
Open Access | Times Cited: 5
Blockade of SK4 channels suppresses atrial fibrillation by attenuating atrial fibrosis in canines with prolonged atrial pacing
Youcheng Wang, Yajun Yao, Yazhe Ma, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 14, pp. 1995-2007
Open Access | Times Cited: 5
Further Quinolizidine Derivatives as Antiarrhythmic Agents. 3
Bruno Tasso, Laura Mattioli, Michele Tonelli, et al.
(2023)
Open Access | Times Cited: 2
RETRACTED: Wound incidence and outcomes in atrial fibrillation: Comparing catheter ablation and anti‐arrhythmic drug therapy
Xinyu Zhou, X. Sheng
International Wound Journal (2023) Vol. 21, Iss. 4
Open Access | Times Cited: 2
Epicardial adipose tissue, obesity, and the occurrence of atrial fibrillation: an overview of pathophysiology and treatment methods
Juan Pablo Scarano Pereira, Eloise Owen, Alessandro Martinino, et al.
Expert Review of Cardiovascular Therapy (2022) Vol. 20, Iss. 4, pp. 307-322
Closed Access | Times Cited: 4
Common Structural Pattern for Flecainide Binding in Atrial-Selective K<sub>v</sub>1.5 and Na<sub>v</sub>1.5 Channels: A Computational Approach
Yuliet Mazola, José Carlos Estanislao Márquez Montesinos, David Ramírez, et al.
(2022)
Open Access | Times Cited: 4
Simultaneous analyses of hemodynamic and electrophysiological effects of oseltamivir along with its pharmacokinetic profile using the canine paroxysmal atrial fibrillation model
Ryuichi Kambayashi, Ai Goto, Mayu Onozato, et al.
Journal of Pharmacological Sciences (2021) Vol. 148, Iss. 1, pp. 179-186
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top